• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

杂合性Brca1突变在胚胎期引发小鼠基因组不稳定。

Heterozygotic Brca1 mutation initiates mouse genome instability at embryonic stage.

作者信息

Wu Xiaobing, Guo Maoni, Cui Jian, Cai Haoyang, Wang San Ming

机构信息

MOE Frontiers Science Center for Precision Oncology, Institute of Translational Medicine, Faculty of Health Sciences, University of Macau, Macau, China.

Eppley Cancer Institute, University of Nebraska Medical Center, Omaha, NE, USA.

出版信息

Oncogenesis. 2022 Jul 22;11(1):41. doi: 10.1038/s41389-022-00417-3.

DOI:10.1038/s41389-022-00417-3
PMID:35869059
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9307611/
Abstract

BRCA1 mutation is the genetic predisposition in causing genome instability towards cancer. BRCA1 mutation is predominantly germline inherited at the fertilization. However, when the inherited mutation initiates genome instability in the mutation carriers remains largely elusive. We used a heterozygotic Brca1-knockout mouse as a model to investigate the issue. Through whole-genome sequencing and bioinformatics analysis, we monitored genome status across the developmental stages from embryo to adulthood in the mouse model. We observed that genome instability as reflected by structural variation, indel and copy number variation already appeared at 10.5-day embryo and progressively towards adulthood. We also observed that the genome instability was not linearly accumulated but dynamically changed along the developmental process, affecting many oncogenic genes and pathways including DNA damage repair, estrogen signaling, and oncogenesis. We further observed that many genome abnormalities in the cancer caused by Brca1 mutation were originated at embryonic stage, and Trp53 (TP53) mutation was not essential for the Brca1 mutation-caused genome instability in the non-cancer cells. Our study revealed that heterozygotic Brca1 mutation alone can cause genome instability at embryonic stage, highlighting that prevention of BRCA1 mutation-related cancer in humans may need to start earlier than currently considered.

摘要

BRCA1突变是导致基因组不稳定进而引发癌症的遗传易感性因素。BRCA1突变主要在受精时通过种系遗传。然而,遗传突变在突变携带者中引发基因组不稳定的机制在很大程度上仍不清楚。我们使用杂合性Brca1基因敲除小鼠作为模型来研究这个问题。通过全基因组测序和生物信息学分析,我们监测了该小鼠模型从胚胎到成年各个发育阶段的基因组状态。我们观察到,由结构变异、插入缺失和拷贝数变异所反映的基因组不稳定在胚胎10.5天时就已出现,并在发育至成年的过程中逐渐加剧。我们还观察到,基因组不稳定并非呈线性累积,而是在发育过程中动态变化,影响了许多致癌基因和信号通路,包括DNA损伤修复、雌激素信号传导和肿瘤发生。我们进一步观察到,由Brca1突变导致的癌症中的许多基因组异常都起源于胚胎期,并且Trp53(TP53)突变对于非癌细胞中Brca1突变引起的基因组不稳定并非必不可少。我们的研究表明,单纯的杂合性Brca1突变就能在胚胎期导致基因组不稳定,这突出表明预防人类BRCA1突变相关癌症可能需要比目前认为的更早开始。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4164/9307611/1ebbbd48f35e/41389_2022_417_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4164/9307611/03ad31d52e4c/41389_2022_417_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4164/9307611/87f5565da92c/41389_2022_417_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4164/9307611/05ac54ea1e04/41389_2022_417_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4164/9307611/336671a215fe/41389_2022_417_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4164/9307611/1ebbbd48f35e/41389_2022_417_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4164/9307611/03ad31d52e4c/41389_2022_417_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4164/9307611/87f5565da92c/41389_2022_417_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4164/9307611/05ac54ea1e04/41389_2022_417_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4164/9307611/336671a215fe/41389_2022_417_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4164/9307611/1ebbbd48f35e/41389_2022_417_Fig5_HTML.jpg

相似文献

1
Heterozygotic Brca1 mutation initiates mouse genome instability at embryonic stage.杂合性Brca1突变在胚胎期引发小鼠基因组不稳定。
Oncogenesis. 2022 Jul 22;11(1):41. doi: 10.1038/s41389-022-00417-3.
2
High chromosome instability identified by low-pass whole-genome sequencing assay is associated with TP53 copy loss and worse prognosis in BRCA1 germline mutation breast cancer.低深度全基因组测序检测到的高染色体不稳定性与 BRCA1 种系突变乳腺癌中的 TP53 拷贝数丢失和预后不良相关。
Breast Cancer. 2022 Jan;29(1):103-113. doi: 10.1007/s12282-021-01286-1. Epub 2021 Aug 17.
3
Genome instability in blood cells of a BRCA1+ breast cancer family.一个携带BRCA1基因的乳腺癌家族血细胞中的基因组不稳定性
BMC Cancer. 2014 May 19;14:342. doi: 10.1186/1471-2407-14-342.
4
Common genetic variants contribute to incomplete penetrance: evidence from cancer-free BRCA1 mutation carriers.常见的遗传变异导致不完全外显:来自无癌症 BRCA1 突变携带者的证据。
Eur J Cancer. 2019 Jan;107:68-78. doi: 10.1016/j.ejca.2018.10.022. Epub 2018 Dec 11.
5
Genomic profiling of breast tumours in relation to BRCA abnormalities and phenotypes.与 BRCA 异常和表型相关的乳腺肿瘤的基因组分析。
Breast Cancer Res. 2009;11(4):R47. doi: 10.1186/bcr2334. Epub 2009 Jul 9.
6
Single-cell analysis of somatic mutation burden in mammary epithelial cells of pathogenic BRCA1/2 mutation carriers.BRCA1/2 致病性突变携带者乳腺上皮细胞体细胞突变负担的单细胞分析。
J Clin Invest. 2022 Mar 1;132(5). doi: 10.1172/JCI148113.
7
Lymphocytes of BRCA1 and BRCA2 germ-line mutation carriers, with or without breast cancer, are not abnormally sensitive to the chromosome damaging effect of moderate folate deficiency.携带BRCA1和BRCA2种系突变的淋巴细胞,无论有无乳腺癌,对中度叶酸缺乏的染色体损伤作用均无异常敏感。
Carcinogenesis. 2006 Mar;27(3):517-24. doi: 10.1093/carcin/bgi226. Epub 2005 Sep 14.
8
Genomic alterations in histopathologically normal breast tissue from BRCA1 mutation carriers may be caused by BRCA1 haploinsufficiency.BRCA1 杂合性不足可能导致组织病理学正常的 BRCA1 突变携带者的乳腺组织中出现基因组改变。
Genes Chromosomes Cancer. 2010 Jan;49(1):78-90. doi: 10.1002/gcc.20723.
9
Mammary tumors in mice conditionally mutant for Brca1 exhibit gross genomic instability and centrosome amplification yet display a recurring distribution of genomic imbalances that is similar to human breast cancer.在Brca1条件性突变的小鼠中,乳腺肿瘤表现出明显的基因组不稳定性和中心体扩增,但仍呈现出与人类乳腺癌相似的基因组失衡复发分布。
Oncogene. 2002 Aug 1;21(33):5097-107. doi: 10.1038/sj.onc.1205636.
10
Whole-genome sequencing analysis of phenotypic heterogeneity and anticipation in Li-Fraumeni cancer predisposition syndrome.李-弗劳梅尼癌症易感性综合征表型异质性和早现现象的全基因组测序分析
Proc Natl Acad Sci U S A. 2014 Oct 28;111(43):15497-501. doi: 10.1073/pnas.1417322111. Epub 2014 Oct 13.

引用本文的文献

1
Human iPSC-based breast cancer model identifies S100P-dependent cancer stemness induced by mutation.基于人诱导多能干细胞的乳腺癌模型确定了由突变诱导的S100P依赖性癌症干性。
Sci Adv. 2025 Jul 25;11(30):eadi2370. doi: 10.1126/sciadv.adi2370.
2
Repetitive Sequence Stability in Embryonic Stem Cells.胚胎干细胞中的重复序列稳定性。
Int J Mol Sci. 2024 Aug 13;25(16):8819. doi: 10.3390/ijms25168819.
3
Oncogenic BRCA1,2 Mutations in the Human Lineage-A By-Product of Sexual Selection?人类谱系中致癌性BRCA1、2基因突变——性选择的副产品?

本文引用的文献

1
Human pathogenic variants were originated during recent human history.人类致病性变异体是在人类近代历史中产生的。
Life Sci Alliance. 2022 Feb 14;5(5). doi: 10.26508/lsa.202101263. Print 2022 May.
2
Pan-Cancer Analysis of and Genomic Alterations and Their Association With Genomic Instability as Measured by Genome-Wide Loss of Heterozygosity.全基因组杂合性缺失所测量的[具体基因]基因组改变及其与基因组不稳定性的关联的泛癌分析
JCO Precis Oncol. 2020;4:442-465. doi: 10.1200/po.19.00345. Epub 2020 Apr 30.
3
Exploiting the Microhomology-Mediated End-Joining Pathway in Cancer Therapy.
Biomedicines. 2023 Dec 21;12(1):22. doi: 10.3390/biomedicines12010022.
4
The Tumor Suppressor BRCA1/2, Cancer Susceptibility and Genome Instability in Gynecological and Mammary Cancers.抑癌基因 BRCA1/2、妇科和乳腺肿瘤的癌症易感性和基因组不稳定性。
Asian Pac J Cancer Prev. 2023 Sep 1;24(9):3139-3153. doi: 10.31557/APJCP.2023.24.9.3139.
5
The Interplay between the Cellular Response to DNA Double-Strand Breaks and Estrogen.细胞对 DNA 双链断裂的反应与雌激素之间的相互作用。
Cells. 2022 Oct 1;11(19):3097. doi: 10.3390/cells11193097.
利用微同源介导的末端连接通路进行癌症治疗。
Cancer Res. 2020 Nov 1;80(21):4593-4600. doi: 10.1158/0008-5472.CAN-20-1672. Epub 2020 Jul 10.
4
NOTCH1 activation compensates BRCA1 deficiency and promotes triple-negative breast cancer formation.NOTCH1 激活补偿 BRCA1 缺陷并促进三阴性乳腺癌的形成。
Nat Commun. 2020 Jun 26;11(1):3256. doi: 10.1038/s41467-020-16936-9.
5
Tracing Oncogene Rearrangements in the Mutational History of Lung Adenocarcinoma.追踪肺腺癌突变历史中的癌基因重排。
Cell. 2019 Jun 13;177(7):1842-1857.e21. doi: 10.1016/j.cell.2019.05.013. Epub 2019 May 30.
6
Tracking Cancer Evolution Reveals Constrained Routes to Metastases: TRACERx Renal.追踪癌症演进揭示转移受限途径:TRACERx 肾脏。
Cell. 2018 Apr 19;173(3):581-594.e12. doi: 10.1016/j.cell.2018.03.057. Epub 2018 Apr 12.
7
Impaired HLA Class I Antigen Processing and Presentation as a Mechanism of Acquired Resistance to Immune Checkpoint Inhibitors in Lung Cancer.肺癌中免疫检查点抑制剂获得性耐药的机制:HLA I 类抗原加工和呈递受损。
Cancer Discov. 2017 Dec;7(12):1420-1435. doi: 10.1158/2159-8290.CD-17-0593. Epub 2017 Oct 12.
8
A mutational signature reveals alterations underlying deficient homologous recombination repair in breast cancer.一种突变特征揭示了乳腺癌中同源重组修复缺陷背后的改变。
Nat Genet. 2017 Oct;49(10):1476-1486. doi: 10.1038/ng.3934. Epub 2017 Aug 21.
9
Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers.BRCA1 和 BRCA2 基因突变携带者的乳腺癌、卵巢癌和对侧乳腺癌风险。
JAMA. 2017 Jun 20;317(23):2402-2416. doi: 10.1001/jama.2017.7112.
10
KEGG: new perspectives on genomes, pathways, diseases and drugs.京都基因与基因组百科全书(KEGG):关于基因组、通路、疾病和药物的新视角。
Nucleic Acids Res. 2017 Jan 4;45(D1):D353-D361. doi: 10.1093/nar/gkw1092. Epub 2016 Nov 28.